45 related articles for article (PubMed ID: 29763615)
1. CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.
Cohen S; Stemmer SM; Zozulya G; Ochaion A; Patoka R; Barer F; Bar-Yehuda S; Rath-Wolfson L; Jacobson KA; Fishman P
J Cell Physiol; 2011 Sep; 226(9):2438-47. PubMed ID: 21660967
[TBL] [Abstract][Full Text] [Related]
2. A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.
Choi IY; Lee JC; Ju C; Hwang S; Cho GS; Lee HW; Choi WJ; Jeong LS; Kim WK
Am J Pathol; 2011 Oct; 179(4):2042-52. PubMed ID: 21854743
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors.
Carlin JL; Tosh DK; Xiao C; Piñol RA; Chen Z; Salvemini D; Gavrilova O; Jacobson KA; Reitman ML
J Pharmacol Exp Ther; 2016 Feb; 356(2):474-82. PubMed ID: 26606937
[TBL] [Abstract][Full Text] [Related]
4. Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists.
Bar-Yehuda S; Barer F; Volfsson L; Fishman P
Neoplasia; 2001; 3(2):125-31. PubMed ID: 11420748
[TBL] [Abstract][Full Text] [Related]
5. Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A
Tosh DK; Salmaso V; Rao H; Bitant A; Fisher CL; Lieberman DI; Vorbrüggen H; Reitman ML; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA
J Med Chem; 2020 Apr; 63(8):4334-4348. PubMed ID: 32271569
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A
Duangrat R; Parichatikanond W; Chanmahasathien W; Mangmool S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891948
[TBL] [Abstract][Full Text] [Related]
7. Cryo-EM structures of adenosine receptor A
Cai H; Guo S; Xu Y; Sun J; Li J; Xia Z; Jiang Y; Xie X; Xu HE
Nat Commun; 2024 Apr; 15(1):3252. PubMed ID: 38627384
[TBL] [Abstract][Full Text] [Related]
8. A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A
Arruda MA; Stoddart LA; Gherbi K; Briddon SJ; Kellam B; Hill SJ
Front Pharmacol; 2017; 8():908. PubMed ID: 29321740
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Lasalocid-Based Bioconjugates and Evaluation of Their Anticancer Activity.
Antoszczak M; Otto-Ślusarczyk D; Kordylas M; Struga M; Huczyński A
ACS Omega; 2022 Jan; 7(2):1943-1955. PubMed ID: 35071884
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer and Purinergic Signalling: An Overview.
Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
[TBL] [Abstract][Full Text] [Related]
11. Regulatory mechanism of miR-20a-5p expression in Cancer.
Huang W; Wu X; Xiang S; Qiao M; Cen X; Pan X; Huang X; Zhao Z
Cell Death Discov; 2022 May; 8(1):262. PubMed ID: 35577802
[TBL] [Abstract][Full Text] [Related]
12. A
Spinaci A; Buccioni M; Dal Ben D; Maggi F; Marucci G; Francucci B; Santoni G; Lambertucci C; Volpini R
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215276
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of 2,6-Disubstituted-4'-Selenoadenosine-5'-
Choi H; Jacobson KA; Yu J; Jeong LS
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33920062
[TBL] [Abstract][Full Text] [Related]
14. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
Fang Z; Xu S; Xie Y; Yan W
World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
[TBL] [Abstract][Full Text] [Related]
15. Purinergic Signaling in the Hallmarks of Cancer.
Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
[TBL] [Abstract][Full Text] [Related]
16. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
Effendi WI; Nagano T; Kobayashi K; Nishimura Y
Cells; 2020 Mar; 9(3):. PubMed ID: 32213945
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity study of A
Marucci G; Santinelli C; Buccioni M; Navia AM; Lambertucci C; Zhurina A; Yli-Harja O; Volpini R; Kandhavelu M
Life Sci; 2018 Jul; 205():155-163. PubMed ID: 29763615
[TBL] [Abstract][Full Text] [Related]
18. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
[TBL] [Abstract][Full Text] [Related]
19. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
Kim TH; Kim YK; Woo JS
Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
